Abstract:Highlights • Identifying the XO inhibitory inhibition of crude extract and fractions. • Eighteen potential XO compounds were isolated and elucidated. • Six XO inhibitors from D. spathacea were identified. • The potency XO inhibitors interact with active site and molybdopterin center of XO. Xanthine oxidase (XO) has been widely recognized as a pivotal enzyme in developing hyperuricemia, primarily contributing to the excessive production of uric acid during purine metabolism in the liver. One of the standard treatment approaches involves reducing uric acid levels by inhibiting XO activity. In this study, the leaf extract of Dolichandrone spathacea , traditionally used in folk medicine, was found to inhibit XO activity in the ethyl acetate and butanol fractions at a concentration of 100 μg/mL, their values were 78.57 ± 3.85 % (IC 50 = 55.93 ± 5.73 μg/ml) and 69.43 ± 8.68 % (IC 50 = 70.17 ± 7.98 μg/ml), respectively. The potential XO inhibitory components were isolated by bioactivity assays and the HR-ESI-MS and NMR spectra system. The main constituents of leaf extracts of Dolichandrone spathacea , six compounds, namely trans- 4-methoxycinnamic acid ( 3 ), trans -3,4-dimethoxycinnamic acid ( 4 ), p -coumaric acid ( 5 ), martynoside ( 6 ), 6-O-( p -methoxy- E -cinnamoyl)-ajugol ( 7 ), and scolymoside ( 17 ), were identified as potent XO inhibitors with IC 50 values ranging from 19.34 ± 1.63 μM to 64.50 ± 0.94 μM. The enzyme kinetics indicated that compounds 3 – 5 , 7 , and 17 displayed competitive inhibition like allopurinol, while compound 6 displayed a mixed-type inhibition. Computational studies corroborated these experimental results, highlighting the interactions between potential metabolites and XO enzyme. The hydrogen bonds played crucial roles in the binding interaction, especially, scolymoside ( 17 ) forms a hydrogen bond with Mos3004, exhibited the lowest binding energy (−18.3286 kcal/mol) corresponding to the lowest IC 50 (19.34 ± 1.63 μM). Furthermore, nine compounds were isolated for the first time from this plant. In conclusion , Dolichandrone spathacea and its constituents possess the potential to modulate the xanthine oxidase enzyme involved in metabolism.

Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies

Identification of Anastatica hierochuntica L. Methanolic-Leaf-Extract-Derived Metabolites Exhibiting Xanthine Oxidase Inhibitory Activities: In Vitro and In Silico Approaches

Xanthine oxidase inhibition study of isolated secondary metabolites from Dolichandrone spathacea (Bignoniaceae): In vitro and in silico approach

In Vitro and in Silico Xanthine Oxidase Inhibitory Activity of Selected Phytochemicals Widely Present in Various Edible Plants.

Bioaffinity ultrafiltration combined with UPLC-ESI-QTrap-MS/MS for screening of xanthine oxidase inhibitors from Paederia foetida L. leaves

Xanthine oxidase inhibitors: Virtual screening and mechanism of inhibition studies

In vitro and in vivo inhibition of xanthine oxidase by the flowers of Chrysanthemum morifolium Ramat.

Design, synthesis, and evaluation of chalcone derivatives as xanthine oxidase inhibitors

Identification of Natural Xanthine Oxidase Inhibitors: Virtual Screening, Anti-Xanthine Oxidase Activity, and Interaction Mechanism.

Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction

Potent Xanthine Oxidase Inhibitory Activity of Constituents of Agastache rugosa (Fisch. and C.A.Mey.) Kuntze

Screening and Evaluation of Flavonoids As Xanthine Oxidase Inhibitors for Reducing Uric Acid Through Combined Cell Biology and Molecular Simulation

[Study on drug-target binding kinetics profiles of flavonoids in Chrysanthemum morifolium and xanthine oxidase]

Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction

Screening of Xanthine Oxidase Inhibitor from Selected Edible Plants and Hypouricemic Effect of Rhizoma Alpiniae Officinarum Extract on Hyperuricemic Rats

A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout: Molecular mechanisms and perspective

Study on the Interaction Mechanism Between Luteoloside and Xanthine Oxidase by Multi‐spectroscopic and Molecular Docking Methods

Design, Synthesis and Biological Evaluation of Novel Xanthine Oxidase Inhibitors Bearing a 2-Arylbenzo[b]furan Scaffold

The research and development prospects of Xanthine oxidase inhibitor

Exploration of Novel Non-Purine Xanthine Oxidase Inhibitors Based on Oxadiazolones by an Integrated Simulation Study

A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics